Zobrazeno 1 - 10 of 1 540 pro vyhledávání: '"Pierangeli S"'
1
Akademický článek
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs).
Autor: Pierangeli S; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy., Donnini S; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy., Ciaurro V; MD Anderson Cancer Center, University of Texas, TX 78712, USA., Milano F; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy., Cardinali V; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy.; Hematology Department, 'Santa Maria della Misericordia' Perugia Hospital, 06129 Perugia, Italy., Sciabolacci S; Hematology Department, 'Santa Maria della Misericordia' Perugia Hospital, 06129 Perugia, Italy., Cimino G; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy.; Hematology Department, 'Santa Maria della Misericordia' Perugia Hospital, 06129 Perugia, Italy., Gionfriddo I; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy., Ranieri R; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy., Cipriani S; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy., Padiglioni E; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy., Iacucci Ostini R; Hematology Department, 'Santa Maria della Misericordia' Perugia Hospital, 06129 Perugia, Italy., Zei T; Hematology Department, 'Santa Maria della Misericordia' Perugia Hospital, 06129 Perugia, Italy., Pierini A; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy.; Hematology Department, 'Santa Maria della Misericordia' Perugia Hospital, 06129 Perugia, Italy., Martelli MP; Hematology and Clinical Immunology Section, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, 06123 Perugia, Italy.; Hematology Department, 'Santa Maria della Misericordia' Perugia Hospital, 06129 Perugia, Italy.
Publikováno v: Cancers [Cancers (Basel)] 2024 Jul 27; Vol. 16 (15). Date of Electronic Publication: 2024 Jul 27.
Zobrazit plný text záznamu
2
Akademický článek
Current status and future perspectives in targeted therapy of NPM1-mutated AML.
Autor: Ranieri R; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Pianigiani G; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Sciabolacci S; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Perriello VM; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Marra A; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Cardinali V; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Pierangeli S; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Milano F; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Gionfriddo I; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Brunetti L; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy.; Department of Molecular and Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy., Martelli MP; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy., Falini B; Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy. brunangelo.falini@unipg.it.
Publikováno v: Leukemia [Leukemia] 2022 Oct; Vol. 36 (10), pp. 2351-2367. Date of Electronic Publication: 2022 Aug 25.
Zobrazit plný text záznamu
5
Akademický článek
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations.
Autor: Spinozzi G; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Tini V; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Ferrari A; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Gionfriddo I; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Ranieri R; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Milano F; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Pierangeli S; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Donnini S; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Mezzasoma F; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Silvestri S; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Falini B; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy., Martelli MP; Department of Medicine and Surgery, Section of Hematology and Clinical Immunology, University of Perugia, 06129 Perugia, Italy.
Publikováno v: Biomolecules [Biomolecules] 2022 Jun 28; Vol. 12 (7). Date of Electronic Publication: 2022 Jun 28.
Zobrazit plný text záznamu
6
Oxidation of beta 2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
Autor: Raimondo, MG, Pericleous, C, Radziszewska, A, Borghi, MO, Pierangeli, S, Meroni, PL, Giles, I, Rahman, A, Ioannou, Y
Domain I (DI) of beta-2-glycoprotein I (β2GPI) contains the immunodominant epitope for pathogenic antiphospholipid antibodies (aPL). DI is exposed in the linear form of the molecule but not in the circular form that comprises 90% of serum β2GPI. Th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::bb8ae2470689d7411a1045bd30232d0c
http://hdl.handle.net/10044/1/62985
Zobrazit plný text záznamu
7
Akademický článek
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
Autor: Pierangeli, S. S.1 sspieran@utmb.edu, Erkan, D.2
Publikováno v: Lupus. Apr2010, Vol. 19 Issue 4, p475-485. 11p. 1 Chart, 1 Graph.
Zobrazit plný text záznamu
8
Akademický článek
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML.
Autor: Gionfriddo I; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Brunetti L; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Mezzasoma F; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Milano F; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Cardinali V; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Ranieri R; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Venanzi A; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Pierangeli S; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Vetro C; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.; Hematology, A.O. 'Policlinico S. Marco', Catania, Italy., Spinozzi G; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Dorillo E; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Wu HC; INSERM U944 and 1050, IRSL, University of Paris and PSL, Hôpital St. Louis and Collége de France, Paris, France., Berthier C; INSERM U944 and 1050, IRSL, University of Paris and PSL, Hôpital St. Louis and Collége de France, Paris, France., Ciurnelli R; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Griffin MJ; Newcastle University Centre for Cancer, Newcastle University, Newcastle, UK., Jennings CE; Newcastle University Centre for Cancer, Newcastle University, Newcastle, UK., Tiacci E; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Sportoletti P; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., Falzetti F; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy., de Thé H; INSERM U944 and 1050, IRSL, University of Paris and PSL, Hôpital St. Louis and Collége de France, Paris, France., Veal GJ; Newcastle University Centre for Cancer, Newcastle University, Newcastle, UK., Martelli MP; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy. maria.martelli@unipg.it., Falini B; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy. brunangelo.falini@unipg.it.
Publikováno v: Leukemia [Leukemia] 2021 Sep; Vol. 35 (9), pp. 2552-2562. Date of Electronic Publication: 2021 Mar 02.
Zobrazit plný text záznamu
10
Measuring IgA anti-beta 2-Glycoprotein I and IgG/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome
Autor: Pericleous, C, Ferreira, I, Borghi, O, Pregnolato, F, McDonnell, T, Garza-Garcia, A, Driscoll, P, Pierangeli, S, Isenberg, D, Ioannou, Y, Giles, I, Meroni, PL, Rahman, A
Introduction Currently available clinical assays to detect antiphospholipid antibodies (aPL) test for IgG and IgM antibodies to cardiolipin (aCL) and β2-glycoprotein I (aβ2GPI). It has been suggested that testing for IgA aPL and for antibodies to D
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::9512814625d82a61832c99a35ff16db0
http://hdl.handle.net/10044/1/68375
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje